www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Allergy immunotherapy
    • Healthcare professionals
      • Reweal
      • Webinars
    • Pipeline
    • Clinical trials
    • Clinical data sharing
  • Our company
    • Newsroom
      • Stories
    • Privacy
    • Global presence
    • Organisation
    • History
    • Owners
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Board of Management
      • Board of Directors
      • Annual general meeting
      • Annual general meeting (DK)
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
      • ADR Programme
    • Contact IR
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

Analyst estimates

Links: 
Dividend history
Analyst coverage
Analyst estimates
Shareholder information
Authorizations
ADR Programme

Glossary »

Stock Information

Price (Prev Close):96.50
Price - 52 Week High:162.10
Price - 52 Week Low:91.75
Price Date (Latest): January 26, 2023
Median Price Target:151.83
Diff from Prev Close:55.33
% Difference:57.34
 

Analyst Ratings

Mean Recommendation:

1.86

Sell

Strong Buy

 

Reference Information

Last Actual (FY0):0.99
FY0 End Date: Dec'21
Ind. Annual Div:--
Hist (5 Yr) Growth %:-6.16
Yield (%):--

Analyst Forecasts

Last Month Revisions

Fiscal PeriodMeanHighLowMedian# of Estimates# Up# DownMean % Change
Annual
Dec'24
3.714.053.463.674--1-4.01
Annual
Dec'23
2.352.542.122.384--1-2.99
Annual
Dec'22
1.531.631.431.534--1-1.29
Quarterly
Dec'22
0.370.470.270.372------

Actuals

Fiscal PeriodReported EPSMean EstimateSurprise % Change
Annual
Dec'21
0.990.876.20
Annual
Dec'20
0.110.33-10.89
Annual
Dec'19
-0.30-0.28-1.36
Quarterly
Sep'22
0.230.163.50
Quarterly
Jun'22
0.190.066.39
Quarterly
Mar'22
0.740.654.38
Quarterly
Dec'21
0.350.207.51
 

P/E Ratios

Fiscal YearFY0FY1FY2
Ratios97.3863.0741.02
 

EPS Growth Rates

Fiscal YOYFY1/FY0FY2/FY1FY3/FY2
Growth Rate76.4753.7657.81

Disclaimer: Mean earnings estimates are calculated by First Call based on their earnings projections made by the analysts who cover ALK. Please note that any opinions, estimates or forecasts regarding ALK's performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of ALK or its management. ALK does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Prices are in DKK

 
  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved